启迪药业：第十届监事会临时会议决议公告

Group 1 - The core point of the article is that Qidi Pharmaceutical announced the approval of the expected daily related transactions for the year 2025 during the temporary meeting of its tenth supervisory board [2] Group 2 - The announcement was made on the evening of September 5 [2] - The decision was made during a temporary meeting of the supervisory board [2] - The company is preparing for its future financial planning and related transactions [2]